XLV250110C133000
- 7.36
- +1.01+15.91%
The Health Care Select Sector SPDR® Fund Newsroom
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC
Assessing AbbVie: Insights From 17 Financial Analysts
Johnson & Johnson Falls After Pausing Varipulse Cases
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Spotlight on Pfizer: Analyzing the Surge in Options Activity
8 Health Care Stocks Whale Activity In Today's Session
Oak Tree Capital's Marks: New things are prone to bubbles, currently private equity buying S&P 500, with a 10-year yield of only ±2%.
Max recently released a memorandum titled "Revisiting the Bubble," stating that investors are currently betting on the leading high-tech companies to maintain their dominance. However, he believes that it is not easy to stay ahead, as new technologies and competitors can surpass existing market leaders at any time. When people assume that "things can only get better" and Buy based on that, the impact of negative news can be particularly severe. He specifically pointed out the frenzy over AI and how this positive sentiment may spread to other Technology sectors.
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Merck Rival Summit Draws New Buy From Truist on Deal Prospects
Pfizer Analyst Ratings
Sector Update: Health Care Stocks Rise Premarket Wednesday
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of FOMC Meeting Minutes
Merck Gets Expanded Approval From China for Its HPV Vaccine in Males
Salesforce To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
AbbVie Analyst Ratings
Merck & Co Analyst Ratings
Merck's male HPV vaccine has been approved domestically for the first time. Industry insiders believe this will promote the future approval of domestic products under development.
① Gardasil has become the first and currently the only approved HPV vaccine for men in China. ② Industry experts believe that the approval of the new indication is a new exploration in terms of pharmacological principles and other aspects. ③ Currently, companies such as Kang Li Wei Shi and Beijing Wantai Biological Pharmacy Enterprise have made arrangements in this field.